Peer-reviewedCC BYAdvanced Science
Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation
4 affiliations
- 1University of Bern
- 2University Hospital Zurich University of Zurich
- 3ETH Zurich
- 4University of Applied Sciences and Arts Northwestern Switzerland
Related
- Therapeutic Potential of Propolis in Ulcerative Colitis: A Review of Preclinical Evidence.
- From Salvia dumetorum Hydroethanolic Extract to Tablet Formulation: Integrated Phytochemical, Biological, and Preclinical Safety Evaluation
- From Formulation Quality to Anti-Tumor Immunity: A Multimodal Imaging and Translational Framework for mRNA–Lipid Nanoparticle Cancer Vaccines in Preclinical Tumor Models
- Multi-cohort meta-analysis, single-cell and Mendelian randomization analyses with experimental validation identify RHBDF2 as a shared mediator of ulcerative colitis and blood-brain barrier disruption.
- A Stream-Function Formulation for the Surface Stokes-Helfrich Model - Surface Finite Element Discretization and Validation
BibTeX
@article{gazzi2026advancing,
title = {{Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation}},
author = {Rafaela Gazzi and Tiziana Cremona and Reto Czekalla and Emily Campbell and Marlene Schwarzfischer and Doris Pöhlmann and Vanessa Dobernig and Gerhard Rogler and Michael Scharl and Alessandra Bergadano and Raffaele Mezzenga and Martin Kuentz and Paola Luciani and Simone Aleandri},
journal = {Advanced Science},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655260},
note = {CC BY},
}
RIS
TY - JOUR
TI - Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation
AU - Rafaela Gazzi
AU - Tiziana Cremona
AU - Reto Czekalla
AU - Emily Campbell
AU - Marlene Schwarzfischer
AU - Doris Pöhlmann
AU - Vanessa Dobernig
AU - Gerhard Rogler
AU - Michael Scharl
AU - Alessandra Bergadano
AU - Raffaele Mezzenga
AU - Martin Kuentz
AU - Paola Luciani
AU - Simone Aleandri
PY - 2026
DA - 2026/10/11
JO - Advanced Science
UR - https://europepmc.org/article/PMC/PMC13655260
SN - 2198-3844
ER -